P. Pharoah

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
20250 citationsauthor #417
Evaluation and comparison of different breast cancer prognosis scores based on gene expression data
202318 citationsauthor #2
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
202320 citationsauthor #102
Predicted proteome association studies of breast, prostate, ovarian, and endometrial cancers implicate plasma protein regulation in cancer susceptibility.
20239 citationsauthor #2
Abstract 6065: Patterns of dysregulated coding and noncoding gene expression in high-grade serous ovarian carcinomas
20230 citationsauthor #12
Abstract 988: Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer
20231 citationsauthor #16
Abstract 3057: Second primary cancer risks for female and male breast cancer survivors
20230 citationsauthor #18
Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling
20221 citationsauthor #8
No association between polygenic risk scores for cancer and development of radiotherapy toxicity.
20225 citationsauthor #27
Abstract OT2-10-02: Mypebs: An international randomized study comparing personalized, risk-stratified to standard breast cancer screening in women aged 40-70
20226 citationsauthor #24
Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis
202213 citationsauthor #7
A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women
20228 citationsauthor #11
eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma.
20226 citationsauthor #15
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
20223 citationsauthor #48
Reproductive factors do not influence survival with ovarian cancer.
20222 citationsauthor #17
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
2022164 citationsauthor #135
Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics.
202224 citationsauthor #49
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
202220 citationsauthor #156
Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals
202117 citationsauthor #54
Polygenic risk scores for prediction of breast cancer risk in Asian populations
202149 citationsauthor #63
Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study
202114 citationsauthor #8
Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response
202112 citationsauthor #23
S45 Meta-analysis of the association between emphysematous change on thoracic CT scan and recurrent pneumothorax
20210 citationsauthor #2
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
20212 citationsauthor #65
A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours
202119 citationsauthor #3
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
20217 citationsauthor #176
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
202131 citationsauthor #326
Genomic Risk Prediction of Coronary Artery Disease in Women with Breast Cancer
202114 citationsauthor #1
Response to Li and Hopper.
20212 citationsauthor #63
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.
202156 citationsauthor #32
Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study.
202132 citationsauthor #55
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
20217 citationsauthor #90
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
202132 citationsauthor #65
Multi-omic machine learning predictor of breast cancer therapy response
2021457 citationsauthor #17
Meta-analysis of the association between emphysematous change on thoracic computerized tomography scan and recurrent pneumothorax
20212 citationsauthor #2
Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
202111 citationsauthor #11
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
20213 citationsauthor #75
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
20215 citationsauthor #43
NHS announces a pilot of a blood test for early detection of many cancers
20216 citationsauthor #2
Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach
20213 citationsauthor #44
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
202114 citationsauthor #147
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
2021795 citationsauthor #188
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
202116 citationsauthor #146
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
202112 citationsauthor #109
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
20218 citationsauthor #274
Cross-ancestry GWAS meta-analysis identifies six new loci for breast cancer in women of African and European ancestry
20211 citationsauthor #9
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women
202136 citationsauthor #40
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
20210 citationsauthor #153
Joint IARC/NCI International Cancer Seminar Series Report: Expert consensus on future directions for ovarian carcinoma research.
20218 citationsauthor #14
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
202151 citationsauthor #4
The challenge of early detection in cancer
2020112 citationsauthor #2
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
202017 citationsauthor #16
Genetically predicted circulating protein biomarkers and ovarian cancer risk.
202024 citationsauthor #5
Abstract 4976: Combining measures of immune infiltration uncovers predictors of survival in high-grade serous ovarian cancer
20200 citationsauthor #8
A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer
202016 citationsauthor #52
Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects.
202049 citationsauthor #65
Genetic Relationship Between Endometriosis and Ovarian Cancer Subtypes
20200 citationsauthor #5
European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
2020102 citationsauthor #53
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
2020323 citationsauthor #15
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium
202058 citationsauthor #96
The 2020 Annual Meeting of the International Genetic Epidemiology Society.
20200 citationsauthor #19
Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants
202060 citationsauthor #55
Prognostic gene expression signature for high-grade serous ovarian cancer
2020112 citationsauthor #123
Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer
20200 citationsauthor #10
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk
202030 citationsauthor #35
Abstract 1194: Cross-cancer GWAS meta-analysis of more than 370,000 cases and 530,000 controls identifies multiple novel cancer risk regions
20200 citationsauthor #24
Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer
202030 citationsauthor #4
Household Fuel Use and the Risk of Gastrointestinal Cancers: The Golestan Cohort Study
202028 citationsauthor #19
Abstract 30: Cross-cancer cross-tissue transcriptome-wide association study (TWAS) of 11 cancers identifies 56 novel genes
20200 citationsauthor #20
Correction to: Overlapping genetic architecture between Parkinson disease and melanoma
20200 citationsauthor #48
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
202035 citationsauthor #20
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement
20208 citationsauthor #15
Association of germline genetic variants with breast cancer survival in patient subgroups defined by standard clinic-pathological variables
20201 citationsauthor #6
Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
202010 citationsauthor #4
Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk
20208 citationsauthor #46
Transcriptome and interactome analyses identify the TP53 interacting gene RCCD1 as a candidate susceptibility gene at the 15p26.1 breast and ovarian cancer risk locus
20202 citationsauthor #12
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
202034 citationsauthor #137
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
202021 citationsauthor #48
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts
202022 citationsauthor #41
Abstract B37: Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer
20200 citationsauthor #23
Cancer Screening, Surrogates of Survival, and the Soma.
202021 citationsauthor #2
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
202081 citationsauthor #9
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
202055 citationsauthor #113
Abstract 3523: MRI-first screening for prostate cancer: A benefit-harm and cost-effectiveness analysis
20200 citationsauthor #4
Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
202024 citationsauthor #17
Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma
202026 citationsauthor #8
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
2020496 citationsauthor #56
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
202016 citationsauthor #55
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
2020155 citationsauthor #63
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations
20208 citationsauthor #97
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses
202047 citationsauthor #75
Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer.
20200 citationsauthor #23
Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study
202083 citationsauthor #18
Identification of novel epithelial ovarian cancer loci in women of African ancestry
202022 citationsauthor #40
Genome-wide association meta-analyses combining multiple risk phenotypes provides insights into the genetic architecture of cutaneous melanoma susceptibility
2020173 citationsauthor #133
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
202030 citationsauthor #34
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
2020147 citationsauthor #60
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer.
2019148 citationsauthor #40
Physical activity and risks of breast and colorectal cancer: A Mendelian randomization analysis
20194 citationsauthor #56
Ovarian Cancer Association Consortium East Asian GWAS summary results
20190 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT